A Phase 1 interventional study of 500 mg acetylsalicylic acid (Aspirin, BAYE4465) and 1000 mg acetylsalicylic acid (Aspirin, BAYE4465) in Moderate Pain, sponsored by Bayer. Completed at 1 site in United Kingdom. Open to male participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-06-06.
Sponsored by Bayer · Phase 1, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 86 studies testing ibuprofen in Pain — 6 open to participants now, 6 under way, none of them phase 3. Ibuprofen · Pain.
Among the 86 studies testing ibuprofen in Pain, this one is the 78th largest by enrollment, is one of 8 that started in 2017, is one of 9 in phase 1, and was the 58th registered.
10,069 studies on the registry are indexed under Pain; 1,651 are open to participants now.
Browse Pain studies →6 of the 86 studies testing ibuprofen in Pain are open now, in 4 countries. Recruiting first, the newest first:
Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi · Sites in Pakistan
Ages 18–60
October University for Modern Sciences and Arts · Sites in Egypt
Ages 6–12
Armed Forces Institute of Dentistry, Pakistan · Sites in Pakistan
Ages 18–50 · Healthy volunteers
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18–80
Benaroya Research Institute · Sites in United States
Ages 18+ · Men only · Healthy volunteers
By country, each count listing its studies:
Ibuprofen: first FDA approval 1974 (MOTRIN), first EMA approval 2004. What it is approved for, and how studies give it, is on its page →
Of the 928 Pain studies recruiting now, 383 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.
This study: 18 Years to 65 Years · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
86 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 11 · Phase 2 10 · Phase 3 22 · Phase 4 30
First in 1998; this study’s year is marked. 8 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 12 is below the median of 66 across 8,502 interventional studies indexed under Pain.
Median enrollment 100 across the 86 interventional studies. Of the 69 that completed or were terminated, 32 (46%) have results posted.
This tab as a report to print or save as PDF → With an account.
33 of 86 have an industry lead sponsor. The 10 most frequent:
Bayer is the lead sponsor of 1,674 studies on the registry; 51 are open to participants now.
Of its 214 completed or terminated interventional studies of FDA-regulated products, 132 (62%) have results posted.
14 studies in Pain by Bayer: none open now, none under way, none of them phase 3. Of 14 finished, 5 (36%) have results posted.
Among the 14 studies in Pain by Bayer, this one is the 14th largest by enrollment, is the only one that started in 2017, is one of 8 in phase 1, and was the 9th registered.
Bayer’s Pain studies by the year they started, since 2007.
2 of the studies testing ibuprofen in Pain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07512297University of GaziantepPain Control During ESWL Using Non-Opioid Analgesics | 2027-01-01 |
| NCT07275710Armed Forces Post Graduate Medical Institute (AFPGMI), RawalpindiRole of Alprazolam in Management of Post Endodontic Pain After Single Visit Root Canal Treatment. To Compare Mean Pain Score Between Two Group of Participants Undergoing Post Operative Pain Management After Single Visit Root Canal Treatment: NSAIDs Alone and a Combination of NSAIDs and Alprazolam. | 2027-01-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 86 studies testing ibuprofen in Pain, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among Bayer’s 14 in Pain:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of this study is to assess disintegration of the new Aspirin disintegrating tablets
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will participant four treatment periods with four different treatments. Treatment assignment adhere to Williams design
Drug: 500 mg acetylsalicylic acid (Aspirin, BAYE4465) · Drug: 1000 mg acetylsalicylic acid (Aspirin, BAYE4465) · Drug: 400 mg ibuprofen(Nurofen) · Drug: 400 mg ibuprofen (Dolormin Extra)
Participants will participant four treatment periods with four different treatments. Treatment assignment adhere to Williams design
Drug: 500 mg acetylsalicylic acid (Aspirin, BAYE4465) · Drug: 1000 mg acetylsalicylic acid (Aspirin, BAYE4465) · Drug: 400 mg ibuprofen(Nurofen) · Drug: 400 mg ibuprofen (Dolormin Extra)
Participants will participant four treatment periods with four different treatments. Treatment assignment adhere to Williams design
Drug: 500 mg acetylsalicylic acid (Aspirin, BAYE4465) · Drug: 1000 mg acetylsalicylic acid (Aspirin, BAYE4465) · Drug: 400 mg ibuprofen(Nurofen) · Drug: 400 mg ibuprofen (Dolormin Extra)
Participants will participant four treatment periods with four different treatments. Treatment assignment adhere to Williams design
Drug: 500 mg acetylsalicylic acid (Aspirin, BAYE4465) · Drug: 1000 mg acetylsalicylic acid (Aspirin, BAYE4465) · Drug: 400 mg ibuprofen(Nurofen) · Drug: 400 mg ibuprofen (Dolormin Extra)
Single intake of 1 tablet, 500mg
Single intake of 1 tablet, 1000mg
Single intake of 1 tablet, 400mg
Single intake of 1 tablet, 400mg
Time to complete tablet disintegration
The tablet is radiolabeled. Scintigraphy images of the abdominal area will be taken It is time until an image with no definable hot spot remaining is identified
Time frame: Up to 4 hours
Gastric empty time, if applicable
Gastric emptying time will be calculated by a qualified assessor based on the scintigraphy images
Time frame: Up to 4 hours
Time of colon arrival, if applicable
Time of colon arrival will be calculated by a qualified assessor based on the scintigraphy images
Time frame: Up to 4 hours
Small intestine transit time, if applicable
Small intestine transit time will be calculated by a qualified assessor based on the scintigraphy images
Time frame: Up to 4 hours
Time of onset of release of radiolabel
Time of onset of release of radiolabel will be calculated by a qualified assessor based on the scintigraphy images
Time frame: Up to 4 hours
Site of onset of release of radiolabel
Site of onset of release of radiolabel will be determined by a qualified assessor based on the scintigraphy images
Time frame: Up to 4 hours
Site of completion of release of radiolabel
Site of completion of release of radiolabel will be determined by a qualified assessor based on the scintigraphy images
Time frame: Up to 4 hours
Disintegration rate of the tablet estimated from the radioactivity remaining
Disintegration rate of the tablet estimated from the radioactivity rem will be calculated by a qualified assessor based on the scintigraphy images
Time frame: Up to 4 hours
Time of 50% disintegration of the tablet estimated from the radioactivity remaining
Time of 50% disintegration of the tablet estimated from the radioactivity remaining will be calculated by a qualified assessor based on the scintigraphy images
Time frame: Up to 4 hours
Gastric emptying kinetics of dispersed radioactive material (t50% and t90%)
Gastric emptying kinetics of dispersed radioactive material (t50% and t90%) will be calculated by a qualified assessor based on the scintigraphy images
Time frame: Up to 4 hours
AUC0-t
Area under the plasma concentration vs time curve from zero to the last data point
Time frame: Prior to dosing (between 60-15 min), and 5, 9, 13, 18, 23, 28, 33, 38, 48, 58, 68, 78, 88, 118, 178 and 238 min post-dose
Cmax
Maximum drug concentration in plasma after single dose administration
Time frame: Prior to dosing (between 60-15 min), and 5, 9, 13, 18, 23, 28, 33, 38, 48, 58, 68, 78, 88, 118, 178 and 238 min post-dose
AUC0-infinity
Area under the plasma concentration vs time curve from zero to infinity
Time frame: Prior to dosing (between 60-15 min), and 5, 9, 13, 18, 23, 28, 33, 38, 48, 58, 68, 78, 88, 118, 178 and 238 min post-dose
t1/2
Half-life associated with the terminal slope
Time frame: Prior to dosing (between 60-15 min), and 5, 9, 13, 18, 23, 28, 33, 38, 48, 58, 68, 78, 88, 118, 178 and 238 min post-dose
tmax
Time to reach maximum drug concentration in the measured
Time frame: Prior to dosing (between 60-15 min), and 5, 9, 13, 18, 23, 28, 33, 38, 48, 58, 68, 78, 88, 118, 178 and 238 min post-dose
Cmax/AUC0-infinity
Time frame: Prior to dosing (between 60-15 min), and 5, 9, 13, 18, 23, 28, 33, 38, 48, 58, 68, 78, 88, 118, 178 and 238 min post-dose
Ran from Aug 2017 to primary completion in Oct 2017, 2 months.
Of 104 industry-sponsored phase 1 interventional studies under Pain, half reached primary completion within 4 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 9. This study's 2 months is below that.
Counting every sponsor, half of 220 studies reached it within 9 months; a quarter within 3 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Aspirin · Ibuprofen